Literature DB >> 12972686

Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity.

Simon W Kok1, Sebastiaan Overeem, Tommy L S Visscher, Gert Jan Lammers, Jaap C Seidell, Hanno Pijl, Arend E Meinders.   

Abstract

OBJECTIVE: To determine the prevalence of obesity among patients with narcolepsy, to estimate associated long-term health risks on the basis of waist circumference, and to distinguish the impact of hypocretin deficiency from that of increased daytime sleepiness (i.e., reduced physical activity) on these anthropometric measures. RESEARCH METHODS AND PROCEDURES: A cross-sectional, case-control study was conducted. Patients with narcolepsy (n = 138) or idiopathic hypersomnia (IH) (n = 33) were included. Age-matched, healthy members of the Dutch population (Monitoring Project on Risk Factors for Chronic Diseases and Doetinchem Project; n = 10,526) were used as controls. BMI and waist circumference were determined.
RESULTS: Obesity (BMI > or = 30 kg/m(2)) and overweight (BMI 25 to 30 kg/m(2)) occurred more often among narcolepsy patients [prevalence: 33% (narcoleptics) vs. 12.5% (controls) and 43% (narcoleptics) vs. 36% (controls), respectively; both p < 0.05]. Narcoleptics had a larger waist circumference (mean difference 5 +/- 1.4 cm, p < 0.001). The BMI of patients with IH was significantly lower than that of narcolepsy patients (25.6 +/- 3.6 vs. 28.5 +/- 5.4 kg/m(2); p = 0.004). DISCUSSION: Overweight and obesity occur frequently in patients with narcolepsy. Moreover, these patients have an increased waist circumference, indicating excess fat storage in abdominal depots. The fact that patients with IH had a lower BMI than narcoleptics supports the notion that excessive daytime sleepiness (i.e., inactivity) cannot account for excess body fat in narcoleptic patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12972686     DOI: 10.1038/oby.2003.156

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  50 in total

Review 1.  Sleep and obesity: a focus on animal models.

Authors:  Vijayakumar Mavanji; Charles J Billington; Catherine M Kotz; Jennifer A Teske
Journal:  Neurosci Biobehav Rev       Date:  2012-01-16       Impact factor: 8.989

Review 2.  Energy expenditure: role of orexin.

Authors:  Jennifer A Teske; Vijayakumar Mavanji
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

Review 3.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

4.  Narcolepsy in African Americans.

Authors:  Makoto Kawai; Ruth O'Hara; Mali Einen; Ling Lin; Emmanuel Mignot
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

Review 5.  The diagnosis and treatment of pediatric narcolepsy.

Authors:  Sona Nevsimalova
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

Review 6.  Circadian rhythms, sleep, and metabolism.

Authors:  Wenyu Huang; Kathryn Moynihan Ramsey; Biliana Marcheva; Joseph Bass
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 7.  Central nervous system regulation of brown adipose tissue.

Authors:  Shaun F Morrison; Christopher J Madden
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

8.  Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.

Authors:  Seiji Nishino; Eiko Sakurai; Sona Nevsimalova; Yasushi Yoshida; Takehiko Watanabe; Kazuhiko Yanai; Emmanuel Mignot
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

9.  Aberrant Food Choices after Satiation in Human Orexin-Deficient Narcolepsy Type 1.

Authors:  Ruth Janke van Holst; Lisa van der Cruijsen; Petra van Mierlo; Gert Jan Lammers; Roshan Cools; Sebastiaan Overeem; Esther Aarts
Journal:  Sleep       Date:  2016-11-01       Impact factor: 5.849

10.  A major role for perifornical orexin neurons in the control of glucose metabolism in rats.

Authors:  Chun-Xia Yi; Mireille J Serlie; Mariette T Ackermans; Ewout Foppen; Ruud M Buijs; Hans P Sauerwein; Eric Fliers; Andries Kalsbeek
Journal:  Diabetes       Date:  2009-07-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.